Biodefense Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 19-Jan-2022
No. of pages: 110

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country's preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

This report contains market size and forecasts of Biodefense in Global, including the following market information:

Global Biodefense Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biodefense market was valued at 1177.1 million in 2021 and is projected to reach US$ 1888.5 million by 2028, at a CAGR of 7.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anthrax Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biodefense include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biodefense companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biodefense Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biodefense Market Segment Percentages, by Type, 2021 (%)

- Anthrax

- Smallpox

- Botulism

- Radiation/Nuclear

- Others

Global Biodefense Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biodefense Market Segment Percentages, by Application, 2021 (%)

- US Military Market

- US Civilian Market

- Non - US Market

Global Biodefense Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biodefense Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biodefense revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biodefense revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Emergent Biosolutions

- Hytest

- GSK

- Sanofi

- PharmAthene

- Bavarian Nordic

- SIGA Technologies

- Arbutus Biopharma

- DynPort Vaccine

- Xoma Corporation

- Ichor Medical Systems

- Aeolus Pharmaceuticals

- Achaogen

- Elusys Therapeutics

- Dynavax Technologies

- Cleveland BioLabs

- Soligenix

- Alnylam Pharmaceuticals

Biodefense Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biodefense Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biodefense Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biodefense Overall Market Size
2.1 Global Biodefense Market Size: 2021 VS 2028
2.2 Global Biodefense Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biodefense Players in Global Market
3.2 Top Global Biodefense Companies Ranked by Revenue
3.3 Global Biodefense Revenue by Companies
3.4 Top 3 and Top 5 Biodefense Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biodefense Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biodefense Players in Global Market
3.6.1 List of Global Tier 1 Biodefense Companies
3.6.2 List of Global Tier 2 and Tier 3 Biodefense Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biodefense Market Size Markets, 2021 & 2028
4.1.2 Anthrax
4.1.3 Smallpox
4.1.4 Botulism
4.1.5 Radiation/Nuclear
4.1.6 Others
4.2 By Type - Global Biodefense Revenue & Forecasts
4.2.1 By Type - Global Biodefense Revenue, 2017-2022
4.2.2 By Type - Global Biodefense Revenue, 2023-2028
4.2.3 By Type - Global Biodefense Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biodefense Market Size, 2021 & 2028
5.1.2 US Military Market
5.1.3 US Civilian Market
5.1.4 Non - US Market
5.2 By Application - Global Biodefense Revenue & Forecasts
5.2.1 By Application - Global Biodefense Revenue, 2017-2022
5.2.2 By Application - Global Biodefense Revenue, 2023-2028
5.2.3 By Application - Global Biodefense Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biodefense Market Size, 2021 & 2028
6.2 By Region - Global Biodefense Revenue & Forecasts
6.2.1 By Region - Global Biodefense Revenue, 2017-2022
6.2.2 By Region - Global Biodefense Revenue, 2023-2028
6.2.3 By Region - Global Biodefense Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biodefense Revenue, 2017-2028
6.3.2 US Biodefense Market Size, 2017-2028
6.3.3 Canada Biodefense Market Size, 2017-2028
6.3.4 Mexico Biodefense Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biodefense Revenue, 2017-2028
6.4.2 Germany Biodefense Market Size, 2017-2028
6.4.3 France Biodefense Market Size, 2017-2028
6.4.4 U.K. Biodefense Market Size, 2017-2028
6.4.5 Italy Biodefense Market Size, 2017-2028
6.4.6 Russia Biodefense Market Size, 2017-2028
6.4.7 Nordic Countries Biodefense Market Size, 2017-2028
6.4.8 Benelux Biodefense Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biodefense Revenue, 2017-2028
6.5.2 China Biodefense Market Size, 2017-2028
6.5.3 Japan Biodefense Market Size, 2017-2028
6.5.4 South Korea Biodefense Market Size, 2017-2028
6.5.5 Southeast Asia Biodefense Market Size, 2017-2028
6.5.6 India Biodefense Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biodefense Revenue, 2017-2028
6.6.2 Brazil Biodefense Market Size, 2017-2028
6.6.3 Argentina Biodefense Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biodefense Revenue, 2017-2028
6.7.2 Turkey Biodefense Market Size, 2017-2028
6.7.3 Israel Biodefense Market Size, 2017-2028
6.7.4 Saudi Arabia Biodefense Market Size, 2017-2028
6.7.5 UAE Biodefense Market Size, 2017-2028
7 Players Profiles
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Corporate Summary
7.1.2 Emergent Biosolutions Business Overview
7.1.3 Emergent Biosolutions Biodefense Major Product Offerings
7.1.4 Emergent Biosolutions Biodefense Revenue in Global Market (2017-2022)
7.1.5 Emergent Biosolutions Key News
7.2 Hytest
7.2.1 Hytest Corporate Summary
7.2.2 Hytest Business Overview
7.2.3 Hytest Biodefense Major Product Offerings
7.2.4 Hytest Biodefense Revenue in Global Market (2017-2022)
7.2.5 Hytest Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Biodefense Major Product Offerings
7.3.4 GSK Biodefense Revenue in Global Market (2017-2022)
7.3.5 GSK Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biodefense Major Product Offerings
7.4.4 Sanofi Biodefense Revenue in Global Market (2017-2022)
7.4.5 Sanofi Key News
7.5 PharmAthene
7.5.1 PharmAthene Corporate Summary
7.5.2 PharmAthene Business Overview
7.5.3 PharmAthene Biodefense Major Product Offerings
7.5.4 PharmAthene Biodefense Revenue in Global Market (2017-2022)
7.5.5 PharmAthene Key News
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporate Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Biodefense Major Product Offerings
7.6.4 Bavarian Nordic Biodefense Revenue in Global Market (2017-2022)
7.6.5 Bavarian Nordic Key News
7.7 SIGA Technologies
7.7.1 SIGA Technologies Corporate Summary
7.7.2 SIGA Technologies Business Overview
7.7.3 SIGA Technologies Biodefense Major Product Offerings
7.7.4 SIGA Technologies Biodefense Revenue in Global Market (2017-2022)
7.7.5 SIGA Technologies Key News
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Corporate Summary
7.8.2 Arbutus Biopharma Business Overview
7.8.3 Arbutus Biopharma Biodefense Major Product Offerings
7.8.4 Arbutus Biopharma Biodefense Revenue in Global Market (2017-2022)
7.8.5 Arbutus Biopharma Key News
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Corporate Summary
7.9.2 DynPort Vaccine Business Overview
7.9.3 DynPort Vaccine Biodefense Major Product Offerings
7.9.4 DynPort Vaccine Biodefense Revenue in Global Market (2017-2022)
7.9.5 DynPort Vaccine Key News
7.10 Xoma Corporation
7.10.1 Xoma Corporation Corporate Summary
7.10.2 Xoma Corporation Business Overview
7.10.3 Xoma Corporation Biodefense Major Product Offerings
7.10.4 Xoma Corporation Biodefense Revenue in Global Market (2017-2022)
7.10.5 Xoma Corporation Key News
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Corporate Summary
7.11.2 Ichor Medical Systems Business Overview
7.11.3 Ichor Medical Systems Biodefense Major Product Offerings
7.11.4 Ichor Medical Systems Biodefense Revenue in Global Market (2017-2022)
7.11.5 Ichor Medical Systems Key News
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Corporate Summary
7.12.2 Aeolus Pharmaceuticals Business Overview
7.12.3 Aeolus Pharmaceuticals Biodefense Major Product Offerings
7.12.4 Aeolus Pharmaceuticals Biodefense Revenue in Global Market (2017-2022)
7.12.5 Aeolus Pharmaceuticals Key News
7.13 Achaogen
7.13.1 Achaogen Corporate Summary
7.13.2 Achaogen Business Overview
7.13.3 Achaogen Biodefense Major Product Offerings
7.13.4 Achaogen Biodefense Revenue in Global Market (2017-2022)
7.13.5 Achaogen Key News
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Corporate Summary
7.14.2 Elusys Therapeutics Business Overview
7.14.3 Elusys Therapeutics Biodefense Major Product Offerings
7.14.4 Elusys Therapeutics Biodefense Revenue in Global Market (2017-2022)
7.14.5 Elusys Therapeutics Key News
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Corporate Summary
7.15.2 Dynavax Technologies Business Overview
7.15.3 Dynavax Technologies Biodefense Major Product Offerings
7.15.4 Dynavax Technologies Biodefense Revenue in Global Market (2017-2022)
7.15.5 Dynavax Technologies Key News
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Corporate Summary
7.16.2 Cleveland BioLabs Business Overview
7.16.3 Cleveland BioLabs Biodefense Major Product Offerings
7.16.4 Cleveland BioLabs Biodefense Revenue in Global Market (2017-2022)
7.16.5 Cleveland BioLabs Key News
7.17 Soligenix
7.17.1 Soligenix Corporate Summary
7.17.2 Soligenix Business Overview
7.17.3 Soligenix Biodefense Major Product Offerings
7.17.4 Soligenix Biodefense Revenue in Global Market (2017-2022)
7.17.5 Soligenix Key News
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Corporate Summary
7.18.2 Alnylam Pharmaceuticals Business Overview
7.18.3 Alnylam Pharmaceuticals Biodefense Major Product Offerings
7.18.4 Alnylam Pharmaceuticals Biodefense Revenue in Global Market (2017-2022)
7.18.5 Alnylam Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Biodefense Market Opportunities & Trends in Global Market
Table 2. Biodefense Market Drivers in Global Market
Table 3. Biodefense Market Restraints in Global Market
Table 4. Key Players of Biodefense in Global Market
Table 5. Top Biodefense Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biodefense Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biodefense Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biodefense Product Type
Table 9. List of Global Tier 1 Biodefense Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biodefense Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biodefense Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biodefense Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biodefense Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Biodefense Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biodefense Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biodefense Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Biodefense Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biodefense Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biodefense Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biodefense Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biodefense Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biodefense Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biodefense Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biodefense Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biodefense Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biodefense Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biodefense Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biodefense Revenue, (US$, Mn), 2023-2028
Table 30. Emergent Biosolutions Corporate Summary
Table 31. Emergent Biosolutions Biodefense Product Offerings
Table 32. Emergent Biosolutions Biodefense Revenue (US$, Mn), (2017-2022)
Table 33. Hytest Corporate Summary
Table 34. Hytest Biodefense Product Offerings
Table 35. Hytest Biodefense Revenue (US$, Mn), (2017-2022)
Table 36. GSK Corporate Summary
Table 37. GSK Biodefense Product Offerings
Table 38. GSK Biodefense Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Biodefense Product Offerings
Table 41. Sanofi Biodefense Revenue (US$, Mn), (2017-2022)
Table 42. PharmAthene Corporate Summary
Table 43. PharmAthene Biodefense Product Offerings
Table 44. PharmAthene Biodefense Revenue (US$, Mn), (2017-2022)
Table 45. Bavarian Nordic Corporate Summary
Table 46. Bavarian Nordic Biodefense Product Offerings
Table 47. Bavarian Nordic Biodefense Revenue (US$, Mn), (2017-2022)
Table 48. SIGA Technologies Corporate Summary
Table 49. SIGA Technologies Biodefense Product Offerings
Table 50. SIGA Technologies Biodefense Revenue (US$, Mn), (2017-2022)
Table 51. Arbutus Biopharma Corporate Summary
Table 52. Arbutus Biopharma Biodefense Product Offerings
Table 53. Arbutus Biopharma Biodefense Revenue (US$, Mn), (2017-2022)
Table 54. DynPort Vaccine Corporate Summary
Table 55. DynPort Vaccine Biodefense Product Offerings
Table 56. DynPort Vaccine Biodefense Revenue (US$, Mn), (2017-2022)
Table 57. Xoma Corporation Corporate Summary
Table 58. Xoma Corporation Biodefense Product Offerings
Table 59. Xoma Corporation Biodefense Revenue (US$, Mn), (2017-2022)
Table 60. Ichor Medical Systems Corporate Summary
Table 61. Ichor Medical Systems Biodefense Product Offerings
Table 62. Ichor Medical Systems Biodefense Revenue (US$, Mn), (2017-2022)
Table 63. Aeolus Pharmaceuticals Corporate Summary
Table 64. Aeolus Pharmaceuticals Biodefense Product Offerings
Table 65. Aeolus Pharmaceuticals Biodefense Revenue (US$, Mn), (2017-2022)
Table 66. Achaogen Corporate Summary
Table 67. Achaogen Biodefense Product Offerings
Table 68. Achaogen Biodefense Revenue (US$, Mn), (2017-2022)
Table 69. Elusys Therapeutics Corporate Summary
Table 70. Elusys Therapeutics Biodefense Product Offerings
Table 71. Elusys Therapeutics Biodefense Revenue (US$, Mn), (2017-2022)
Table 72. Dynavax Technologies Corporate Summary
Table 73. Dynavax Technologies Biodefense Product Offerings
Table 74. Dynavax Technologies Biodefense Revenue (US$, Mn), (2017-2022)
Table 75. Cleveland BioLabs Corporate Summary
Table 76. Cleveland BioLabs Biodefense Product Offerings
Table 77. Cleveland BioLabs Biodefense Revenue (US$, Mn), (2017-2022)
Table 78. Soligenix Corporate Summary
Table 79. Soligenix Biodefense Product Offerings
Table 80. Soligenix Biodefense Revenue (US$, Mn), (2017-2022)
Table 81. Alnylam Pharmaceuticals Corporate Summary
Table 82. Alnylam Pharmaceuticals Biodefense Product Offerings
Table 83. Alnylam Pharmaceuticals Biodefense Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biodefense Segment by Type in 2021
Figure 2. Biodefense Segment by Application in 2021
Figure 3. Global Biodefense Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biodefense Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biodefense Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biodefense Revenue in 2021
Figure 8. By Type - Global Biodefense Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biodefense Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biodefense Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biodefense Revenue Market Share, 2017-2028
Figure 12. US Biodefense Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biodefense Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biodefense Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biodefense Revenue Market Share, 2017-2028
Figure 16. Germany Biodefense Revenue, (US$, Mn), 2017-2028
Figure 17. France Biodefense Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biodefense Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biodefense Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biodefense Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biodefense Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biodefense Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biodefense Revenue Market Share, 2017-2028
Figure 24. China Biodefense Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biodefense Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biodefense Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biodefense Revenue, (US$, Mn), 2017-2028
Figure 28. India Biodefense Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biodefense Revenue Market Share, 2017-2028
Figure 30. Brazil Biodefense Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biodefense Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biodefense Revenue Market Share, 2017-2028
Figure 33. Turkey Biodefense Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biodefense Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biodefense Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biodefense Revenue, (US$, Mn), 2017-2028
Figure 37. Emergent Biosolutions Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hytest Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GSK Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PharmAthene Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bavarian Nordic Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. SIGA Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Arbutus Biopharma Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. DynPort Vaccine Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Xoma Corporation Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ichor Medical Systems Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Aeolus Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Achaogen Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Elusys Therapeutics Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Dynavax Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Cleveland BioLabs Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Soligenix Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Alnylam Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

  • Global Biodefense Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global Biodefense market size was valued at US$ 1119.1 million in 2023. With growing demand in downstream market, the Biodefense is forecast to a readjusted size of US$ 1865.5 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Biodefense market. Biodefense are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Military Aerospace Simulation and Training Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Military Aerospace Simulation and Training market size was valued at US$ 10720 million in 2023. With growing demand in downstream market, the Military Aerospace Simulation and Training is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Military Aerospace Simulation and Training market. Military Aerospace Simu......
  • Global Shooting Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 129
    According to our LPI (LP Information) latest study, the global Shooting market size was valued at US$ 3522.7 million in 2023. With growing demand in downstream market, the Shooting is forecast to a readjusted size of US$ 5487 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Shooting market. Shooting are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Unattended Ground Sensor Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Unattended Ground Sensor market size was valued at US$ 2040.6 million in 2023. With growing demand in downstream market, the Unattended Ground Sensor is forecast to a readjusted size of US$ 2847.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Unattended Ground Sensor market. Unattended Ground Sensor are expected to show stable growth in the future m......
  • Global Autonomous Underwater Vehicles (AUV) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Autonomous Underwater Vehicles (AUV) market: According to our latest research, the global Autonomous Underwater Vehicles (AUV) market looks promising in the next 5 years. As of 2022, the global Autonomous Underwater Vehicles (AUV) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and ......
  • Global Autonomous Underwater Vehicles Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 162
    An autonomous underwater vehicle is a robot that travels underwater without requiring input from an operator. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and m......
  • Global Autonomous Underwater Vehicles Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 109
    An autonomous underwater vehicle is a robot that travels underwater without requiring input from an operator. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and m......
  • Global Counter Unmanned Aerial Vehicle Defense System Market Research Report 2023, Forecast to 2028
    Published: 21-Dec-2023        Price: US 2680 Onwards        Pages: 179
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Counter Unmanned Aerial Vehicle Defense System Professional Survey Report 2023, Forecast to 2028
    Published: 21-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs